Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05141266 · ClinicalTrials.gov registry record · NA
Healthy Opioid Prescription Engagement
A NA study of Opioid-Related Disorders and Opioid Misuse, sponsored by Jerry Cochran.
- Active
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT05141266: Active NA study of Opioid-Related Disorders and Opioid Misuse, sponsored by Jerry Cochran.
NCT05141266 is a NA study of Opioid-Related Disorders and Opioid Misuse that is active but no longer recruiting, run by Jerry Cochran. The registered enrollment target is 350 participants, roughly in line with the 339-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05141266, a NA study of Opioid-Related Disorders and Opioid Misuse, is active but no longer recruiting, sponsored by Jerry Cochran.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized controlled trial across 14 community pharmacies to test the efficacy of the Brief Intervention-Medication Therapy Management intervention (BI-MTM). The establishment of the BI-MTM model will result in a major impact for addressing the opioid epidemic, preventing opioid use disorder and overdose, and safeguarding patient health in a novel community-based service setting.
Primary Outcome
This outcome will be assessed using the Prescription Opioid Misuse Index (POMI).
Conditions Studied
Interventions
- BEHAVIORAL Patient Navigation
- OTHER Standard Medication Counseling (SMC)
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2021-11-08 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What the registry record for NCT05141266 still lists
NCT05141266 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 339-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target.
The record links to 3 conditions, with Opioid-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which Patient Navigation is the first listed.
NCT05141266 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT05141266 about?
NCT05141266 is a clinical study titled "Healthy Opioid Prescription Engagement". This study is a randomized controlled trial across 14 community pharmacies to test the efficacy of the Brief Intervention-Medication Therapy Management intervention (BI-MTM). The establishment of the BI-MTM model will result in a major impact for addressing the opioid epidemic, preventing opioid use...
What is the current status of trial NCT05141266?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2021-11-08. Estimated completion is 2026-07-01.
What conditions does trial NCT05141266 study?
This clinical trial studies the following conditions: Opioid-Related Disorders, Opioid Misuse, Pharmacist-Patient Relations.
What interventions are being tested in trial NCT05141266?
The interventions under investigation include: Patient Navigation (BEHAVIORAL), Standard Medication Counseling (SMC) (OTHER).
Who is sponsoring clinical trial NCT05141266?
This trial is sponsored by Jerry Cochran, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05141266 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05141266's enrollment target sits among peer trials
350 10th of 47 higher than 38 of 47 other Opioid-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
RECRUITING · NA
-
Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment
RECRUITING · NA
-
OUD Smartphone Services
ACTIVE NOT RECRUITING · NA
-
Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing
ACTIVE NOT RECRUITING · NA
-
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
ACTIVE NOT RECRUITING · NA
-
More Individualized Care: Assessment and Recovery Through Engagement
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI